mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |